Early detection of pancreatic cancer: Risk factors and the current state of screening modalities

Research output: Contribution to journalArticlepeer-review

Abstract

Pancreatic cancer (PC) is expected to become the second leading cause of cancer-related mortality in the United States within the next decade. Patients often present at late stages of the disease, when they become symptomatic; in many cases, these patients have unresectable disease that is associated with a poor prognosis. Considering the low incidence of PC in the general population, routine screening of average-risk individuals is not feasible and not recommended. Individuals with familial germline mutations or familial PC are at higher risk of developing PC. Improving detection of PC at an earlier stage entails the recognition of high-risk individuals who may benefit from a long-term screening program. This article identifies patients who may be at increased risk of developing PC, discusses PC screening recommendations, and compares imaging-based modalities and biomarkers for early detection of PC.

Original languageEnglish (US)
Pages (from-to)254-262
Number of pages9
JournalGastroenterology and Hepatology
Volume17
Issue number6
StatePublished - Jun 2021

Keywords

  • Biomarker
  • Endoscopic ultrasound
  • Familial pancreatic cancer
  • Pancreatic cancer
  • Screening

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint

Dive into the research topics of 'Early detection of pancreatic cancer: Risk factors and the current state of screening modalities'. Together they form a unique fingerprint.

Cite this